Kamada Ltd. Logo

Kamada Ltd.

KMDA | TA

Overview

Corporate Details

ISIN(s):
IL0010941198
LEI:
Country:
Israel
Address:
2 Holzman St, Science Park, 7670402 Rehovot
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Kamada Ltd. is a vertically integrated global biopharmaceutical company focused on specialty plasma-derived therapeutics. The company develops, produces, and markets a portfolio of pharmaceuticals for rare and serious conditions, utilizing a proprietary platform technology for the extraction and purification of proteins from human plasma. Its key therapeutic areas include Alpha-1 Antitrypsin Deficiency (AATD), rabies prophylaxis, and prevention of cytomegalovirus (CMV) in transplant recipients. Kamada maintains a diverse portfolio of marketed products and a robust development pipeline, supported by industry-leading manufacturing and protein separation capabilities.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Kamada Ltd.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-13 16:00
Foreign Filer Report
Second Quarter and First Half 2025 Financial Results
English 4.1 MB
2025-08-13 16:00
Foreign Filer Report
Second Quarter and First Half 2025 Financial Results
English 36.8 KB
2025-08-11 16:00
Foreign Filer Report
FDA Approval of its Plasma Collection Center in Houston, Texas
English 184.4 KB
2025-08-11 16:00
Report Publication Announcement
FDA Approval of its Plasma Collection Center in Houston, Texas
English 36.5 KB
2025-08-06 16:05
Foreign Filer Report
to Announce Second Quarter and First Half Ended June 30, 2025, Financial Result…
English 155.6 KB
2025-08-06 16:05
Foreign Filer Report
to Announce Second Quarter and First Half Ended June 30, 2025, Financial Result…
English 36.5 KB
2025-08-05 17:33
Regulatory News Service
Due to an error, trade halt was initiated in KAMADA's shares instead of CAMTEK'…
Hebrew (modern) 62.0 KB
2025-06-17 16:00
Foreign Filer Report
Kamada Confirms Continuous Global Business Operations and Products Availability…
English 134.2 KB
2025-06-17 16:00
Regulatory News Service
Kamada Confirms Continuous Global Business Operations and Products Availability…
English 36.6 KB
2025-05-14 16:00
Foreign Filer Report
Kamada Reports Strong First Quarter 2025 Financial Results with Year Over Year …
English 8.4 MB
2025-05-14 16:00
Earnings Release
Kamada Reports Strong First Quarter 2025 Financial Results with Year Over Year …
English 36.5 KB
2025-05-07 16:00
Foreign Filer Report
Kamada to Announce First Quarter 2025 Financial Results on May 14, 2025
English 151.4 KB
2025-05-07 16:00
Report Publication Announcement
Kamada to Announce First Quarter 2025 Financial Results on May 14, 2025
English 36.3 KB
2025-05-05 16:00
Foreign Filer Report
Kamada Announces Launch of a Comprehensive Post-Marketing Research Program for …
English 178.4 KB
2025-05-05 16:00
Foreign Filer Report
Kamada Announces Launch of a Comprehensive Post-Marketing Research Program for …
English 36.5 KB

Automate Your Workflow. Get a real-time feed of all Kamada Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Kamada Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
ObsEva SA Logo
Developed therapeutics for women's reproductive health and pregnancy; now winding down operations.
Switzerland OBSN
ODI Pharma AB Logo
Produces and distributes pharmaceutical-grade medicinal cannabis products across Europe.
Sweden ODI
Oncolys BioPharma Inc. Logo Japan 4588
Oncopeptides Logo
Develops targeted therapies for hematological cancers using peptide-drug conjugate technology.
Sweden ONCO
OncoTherapy Science, Inc. Logo Japan 4564
Onesano S.A. Logo
Develops patented nutritional products for humans, animals, and agriculture.
Poland SKT
ONO PHARMACEUTICAL CO., LTD. Logo Japan 4528
OPKO Health Inc. Logo
Provides clinical diagnostics & develops novel therapies for serious & pediatric diseases.
Israel OPK
Orexo Logo
Develops pharmaceuticals for opioid use disorder and pain using innovative drug delivery technology.
Sweden ORX
Orion Oyj Logo
Develops and markets human/vet pharmaceuticals and APIs, focusing on oncology and pain management.
Finland ORNAV